Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma

Clinical trial NCT05076513 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05076513
Sponsor: Nader Sanai
Status: ACTIVE_NOT_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Glioblastoma Glioblastoma Multiforme Glioma GBM Glioma, Malignant Glioblastoma Multiforme of Brain

Start date: 2021-10-29
Primary completion: 2024-03-19
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.